GlassScriptPhysician profile
David Y Kim
NPI 1528056777
$3,194.99
in general payments reported to CMS, 2019-2025
21 companies · $1,872 in 2025
The $1,872 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $41.58 · 2021: $315 · 2022: $183 · 2023: $218 · 2024: $425 · 2025: $1,872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Food and Beverage: $866 · Consulting Fee: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Food and Beverage | $865.74 |
| Consulting Fee | $650.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $1,000.00 | 2025 | |
| Maquet Cardiopulmonary Gmbh | $650.00 | 2025 | Hls Set |
| Cook Medical LLC | $353.19 | 2021-2022 | |
| Mentor Worldwide LLC | $296.87 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Cumberland Pharmaceuticals, INC. | $224.56 | 2020-2025 | Caldolor |
| Si-Bone, INC. | $125.53 | 2023 | |
| Comsort, INC | $100.00 | 2019 | |
| Coherus Oncology, INC. | $85.09 | 2023-2024 | |
| Meridian Bioscience INC. | $56.48 | 2024 | |
| Sandoz INC. | $48.17 | 2024 | Cimerli |
| Chiesi USA, INC. | $42.06 | 2019-2021 | |
| Lilly USA, LLC | $39.07 | 2024 | Omvoh |
| Ambu INC. | $30.38 | 2020 | |
| Solta Medical, A Division of Bausch Health US, LLC | $26.28 | 2024 | |
| Heron Therapeutics, INC. | $25.26 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $17.77 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $16.41 | 2023 | Bridion |
| Novo Nordisk INC | $16.17 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.06 | 2023 | Exparel, Iovera, Zilretta |
| Trevena, INC. | $14.69 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.